Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by captwadeon Aug 26, 2020 1:11pm
268 Views
Post# 31456336

Time to put on the Big-Boy pants.

Time to put on the Big-Boy pants.When a company is trying to stimulate the share price they should at least take advantage of the more obvious ways to do so.

These guys missed an obvious opportunity to revise the sales projections for this year.  Did they not predict 10% sales growth?  With first 6 months up 43% and most recent quarter up 53% the year would finish up 21% even if Q3 and Q4 were totally flat, something which seems highly unlikely at this point. 

It was good to see the TMX site revised to reflect the current financials by showing a P/E of 30 and as Fossi mentioned recently we are trending towards a year end P/E of 13 or so.

There is little not to like with Ceapro currently and those of us who hold shares are probably in for a nice ride.
<< Previous
Bullboard Posts
Next >>